Cabaletta Bio | SC 13G:超過5%持股股東披露文件
Cabaletta Bio | SC 13G:超過5%持股股東披露文件-Jennison Associates LLC(11.1%)
Cabaletta Bio | 4:持股變動聲明-董事 Bollard Catherine
Cabaletta Bio | 4:持股變動聲明-董事 Simon Mark
Cabaletta Bio | 4:持股變動聲明-董事 HENRIQUES RICHARD C JR
Cabaletta Bio | 4:持股變動聲明-董事 Brun Scott C.
Cabaletta Bio | 4:持股變動聲明-董事 Tomasello Shawn
Cabaletta Bio | 4:持股變動聲明-高管 Gerard Michael
Cabaletta Bio | 4:持股變動聲明-高管 Chang David J.
Cabaletta Bio | 4:持股變動聲明-高管 Nichtberger Steven
Cabaletta Bio | 4:持股變動聲明-高管 Das Arun
Cabaletta Bio | 4:持股變動聲明-高管 Marda Anup
Cabaletta Bio | 4:持股變動聲明-高管 Binder Gwendolyn
Cabaletta Bio | SC 13G/A:超過5%持股股東披露文件(修正)-Commodore Capital LP(4.4%),Commodore Capital Master LP(4.4%)
Cabaletta Bio | SC 13G/A:超過5%持股股東披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(6.4%),VHCP Co-Investment Holdings III, LLC(6.4%)等
Cabaletta Bio | SC 13G/A:超過5%持股股東披露文件(修正)-Alger Associates, Inc.(7.8%)
Cabaletta Bio | SC 13G/A:超過5%持股股東披露文件(修正)-Baker Bros. Advisors LP(3.4%),Baker Bros. Advisors (GP) LLC(3.4%)等
Cabaletta Bio | SC 13G/A:超過5%持股股東披露文件(修正)-Cormorant Global Healthcare Master Fund, LP(0.00%),Cormorant Global Healthcare GP, LLC(0.00%)等
Cabaletta Bio | SC 13G/A:超過5%持股股東披露文件(修正)-Lynx1 Capital Management LP(4.99%),Weston Nichols(4.99*%)
Cabaletta Bio | SC 13G/A:超過5%持股股東披露文件(修正)-Bain Capital Life Sciences Opportunities III, LP(4.7%)
暫無數據